Azacitidine in a patient with newly diagnosed acute myeloid leukemia and poor risk cytogenetics: outcomes of prolonged therapy

Leuk Res. 2012 Apr;36(4):e78-80. doi: 10.1016/j.leukres.2011.11.022. Epub 2011 Dec 26.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Abnormal Karyotype
  • Aged
  • Antimetabolites, Antineoplastic / administration & dosage*
  • Azacitidine / administration & dosage*
  • Female
  • Follow-Up Studies
  • Humans
  • Leukemia, Myeloid, Acute / drug therapy*
  • Leukemia, Myeloid, Acute / genetics
  • Randomized Controlled Trials as Topic
  • Risk
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Azacitidine